Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors

NCT02636036 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Squamous Cell Carcinoma of the Head and Neck
Epithelial Tumor

Interventions

BIOLOGICAL: enadenotucirev
BIOLOGICAL: nivolumab

Sponsor

Akamis Bio

Collaborators

[object Object]
[object Object]